Compare ARK Genomic Revolution ETF (ARKG) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares Ultra Semiconductors — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while ProShares Ultra Semiconductors trades at $92.97. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares Ultra Semiconductors nearer its low. Which is the better fit depends on your goals.
| ARKG | USD | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $113.53 |
52-Week Low | $23.09 | $38.89 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
USD stock trades at $96.96, up 3.09% today, but technical indicators show a bearish bias with mixed signals. The stock faces resistance near $99 and support at $92. Recent news highlights include earnings reports from various companies, though specific financials for USD are not detailed in the provided data. The overall market sentiment is cautious, with oscillators neutral and moving averages slightly bullish.
The outlook for USD is clouded by bearish technicals and limited fundamental data. Investment opportunities may arise if the stock breaks above resistance, but risks include market volatility and lack of recent earnings visibility. Investors should await clearer financial updates to assess valuation and growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
